256 related articles for article (PubMed ID: 31288243)
1. Outpatient Parenteral Antimicrobial Treatment for Non-Cystic Fibrosis Bronchiectasis Exacerbations: A Prospective Multicentre Observational Cohort Study.
López-Cortés LE; Ayerbe-García R; Carrasco-Hernández L; Fraile-Ramos E; Carmona-Caballero JM; Quintana-Gallego E; Valido-Morales A; Praena J; Pachón-Diaz J;
Respiration; 2019; 98(4):294-300. PubMed ID: 31288243
[TBL] [Abstract][Full Text] [Related]
2. Clinical characteristics and outcomes of patients receiving outpatient parenteral antibiotic therapy in a Belgian setting: a single-center pilot study.
Briquet C; Cornu O; Servais V; Blasson C; Vandeleene B; Yildiz H; Stainier A; Yombi JC
Acta Clin Belg; 2020 Aug; 75(4):275-283. PubMed ID: 31023169
[TBL] [Abstract][Full Text] [Related]
3. Self-administered outpatient parenteral antimicrobial therapy (S-OPAT) for infective endocarditis: a safe and effective model.
Pajarón M; Fernández-Miera MF; Allende I; Arnaiz AM; Gutiérrez-Cuadra M; Cobo-Belaustegui M; Armiñanzas C; de Berrazueta JR; Fariñas MC; Sanroma P;
Eur J Intern Med; 2015 Mar; 26(2):131-6. PubMed ID: 25596808
[TBL] [Abstract][Full Text] [Related]
4. Assessing effects of inhaled antibiotics in adults with non-cystic fibrosis bronchiectasis--experiences from recent clinical trials.
Paredes Aller S; Quittner AL; Salathe MA; Schmid A
Expert Rev Respir Med; 2018 Sep; 12(9):769-782. PubMed ID: 30025482
[TBL] [Abstract][Full Text] [Related]
5. Self-Administered Outpatient Antimicrobial Infusion by Uninsured Patients Discharged from a Safety-Net Hospital: A Propensity-Score-Balanced Retrospective Cohort Study.
Bhavan KP; Brown LS; Haley RW
PLoS Med; 2015 Dec; 12(12):e1001922. PubMed ID: 26671467
[TBL] [Abstract][Full Text] [Related]
6. Outpatient parenteral antibiotic therapy (OPAT) for the management of bronchiectasis.
Tu J; Al Harasi M; Pallin M; Daley C; Rogers BA; King PT
Heliyon; 2023 Sep; 9(9):e19968. PubMed ID: 37809890
[TBL] [Abstract][Full Text] [Related]
7. Incidence of patients with non-cystic fibrosis bronchiectasis in Germany - A healthcare insurance claims data analysis.
Diel R; Ewig S; Blaas S; Jacob C; Juelich F; Korfmann G; Sohrab S; Sutharsan S; Rademacher J
Respir Med; 2019 May; 151():121-127. PubMed ID: 31047108
[TBL] [Abstract][Full Text] [Related]
8. The RESPIRE trials: Two phase III, randomized, multicentre, placebo-controlled trials of Ciprofloxacin Dry Powder for Inhalation (Ciprofloxacin DPI) in non-cystic fibrosis bronchiectasis.
Aksamit T; Bandel TJ; Criollo M; De Soyza A; Elborn JS; Operschall E; Polverino E; Roth K; Winthrop KL; Wilson R
Contemp Clin Trials; 2017 Jul; 58():78-85. PubMed ID: 28495619
[TBL] [Abstract][Full Text] [Related]
9. Spotlight on inhaled ciprofloxacin and its potential in the treatment of non-cystic fibrosis bronchiectasis.
Chorepsima S; Kechagias KS; Kalimeris G; Triarides NA; Falagas ME
Drug Des Devel Ther; 2018; 12():4059-4066. PubMed ID: 30568427
[TBL] [Abstract][Full Text] [Related]
10. Role of outpatient parenteral antibiotic therapy in the treatment of community acquired skin and soft tissue infections in Singapore.
Chan M; Ooi CK; Wong J; Zhong L; Lye D
BMC Infect Dis; 2017 Jul; 17(1):474. PubMed ID: 28683717
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of outpatient parenteral antibiotic therapy for infective endocarditis: a ten-year prospective study.
Cervera C; del Río A; García L; Sala M; Almela M; Moreno A; Falces C; Mestres CA; Marco F; Robau M; Gatell JM; Miró JM;
Enferm Infecc Microbiol Clin; 2011 Oct; 29(8):587-92. PubMed ID: 21723004
[TBL] [Abstract][Full Text] [Related]
12. Review of the first comprehensive outpatient parenteral antimicrobial therapy program in a tertiary care hospital in Japan.
Hase R; Yokoyama Y; Suzuki H; Uno S; Mikawa T; Suzuki D; Muranaka K; Hosokawa N
Int J Infect Dis; 2020 Jun; 95():210-215. PubMed ID: 32205285
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of an emergency department to outpatient parenteral antibiotic therapy program for cellulitis.
Yadav K; Suh KN; Eagles D; Thiruganasambandamoorthy V; Wells GA; Stiell IG
Am J Emerg Med; 2019 Nov; 37(11):2008-2014. PubMed ID: 30824277
[TBL] [Abstract][Full Text] [Related]
14. Inhaled antibiotics for treatment of adults with non-cystic fibrosis bronchiectasis: A systematic review and meta-analysis.
Tejada S; Campogiani L; Solé-Lleonart C; Gómez A; Gallego M; Vendrell M; Soriano JB; Rello J
Eur J Intern Med; 2021 Aug; 90():77-88. PubMed ID: 33947626
[TBL] [Abstract][Full Text] [Related]
15. Inhaled liposomal ciprofloxacin in patients with non-cystic fibrosis bronchiectasis and chronic lung infection with Pseudomonas aeruginosa (ORBIT-3 and ORBIT-4): two phase 3, randomised controlled trials.
Haworth CS; Bilton D; Chalmers JD; Davis AM; Froehlich J; Gonda I; Thompson B; Wanner A; O'Donnell AE
Lancet Respir Med; 2019 Mar; 7(3):213-226. PubMed ID: 30658914
[TBL] [Abstract][Full Text] [Related]
16. The effect of N-acetylcysteine in patients with non-cystic fibrosis bronchiectasis (NINCFB): study protocol for a multicentre, double-blind, randomised, placebo-controlled trial.
Liao Y; Wu Y; Zi K; Shen Y; Wang T; Qin J; Chen L; Chen M; Liu L; Li W; Zhou H; Xiong S; Wen F; Chen J
BMC Pulm Med; 2022 Nov; 22(1):401. PubMed ID: 36344940
[TBL] [Abstract][Full Text] [Related]
17. [The first trial of OPAT (outpatient parenteral antimicrobial therapy) with continuous infusions in Japan].
Hase R; Hosokawa N; Uno S; Mikawa T; Uwamino Y; Muranaka K
Kansenshogaku Zasshi; 2014 May; 88(3):269-74. PubMed ID: 24974449
[TBL] [Abstract][Full Text] [Related]
18. Monitoring of Outpatient Parenteral Antimicrobial Therapy and Implementation of Clinical Pharmacy Services at a Community Hospital Infusion Unit.
Shah PJ; Bergman SJ; Graham DR; Glenn S
J Pharm Pract; 2015 Oct; 28(5):462-8. PubMed ID: 25107418
[TBL] [Abstract][Full Text] [Related]
19. The use, appropriateness and outcomes of outpatient parenteral antimicrobial therapy.
Hodgson KA; Huynh J; Ibrahim LF; Sacks B; Golshevsky D; Layley M; Spagnolo M; Raymundo CM; Bryant PA
Arch Dis Child; 2016 Oct; 101(10):886-93. PubMed ID: 27166221
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of oral amoxicillin-clavulanate or azithromycin for non-severe respiratory exacerbations in children with bronchiectasis (BEST-1): a multicentre, three-arm, double-blind, randomised placebo-controlled trial.
Goyal V; Grimwood K; Ware RS; Byrnes CA; Morris PS; Masters IB; McCallum GB; Binks MJ; Smith-Vaughan H; O'Grady KF; Champion A; Buntain HM; Schultz A; Chatfield M; Torzillo PJ; Chang AB
Lancet Respir Med; 2019 Sep; 7(9):791-801. PubMed ID: 31427252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
